Core Insights - The successful listing of the Invesco Great Wall ChiNext 50 ETF Depository Receipts on the Thailand Stock Exchange marks the first time a Chinese A-share ETF has been listed in Thailand, enhancing financial cooperation between China and Thailand [1][2] - The demand for investment in Chinese core assets is rapidly increasing among Thai investors, driven by China's high-quality economic development and capital market reforms [2][3] - The ChiNext 50 Index focuses on high-tech industries such as new energy, advanced manufacturing, and biomedicine, making it an attractive investment for Thai investors looking to capture the benefits of China's technological advancements [3][4] Market Performance - The ChiNext 50 Index has shown strong performance, with a cumulative increase of over 51% as of November 18, outperforming other broad-based indices [3][4] - The average revenue growth rate for the index's constituent stocks was 21.07% year-on-year in the mid-2025 reporting season, with net profit growth at 16.63% [4] - In the third quarter, the revenue growth rate for the constituent stocks remained robust at 15.75%, while net profit growth increased to 22.58% [4] Sector Analysis - The ChiNext 50 Index is heavily weighted towards high-growth sectors, with significant representation from batteries (29.76%), communication equipment (18.62%), and photovoltaic equipment (8.22%) [5] - The index's top ten constituent stocks have shown exceptional growth, with an average revenue growth rate of 48.93% and net profit growth of 82.03% [4][5] - The index aims to support innovative enterprises in sectors with international competitiveness, contributing to the global value chain and enhancing the performance of ChiNext 50 companies [5]

Core Viewpoint - The listing of the ChiNext 50 ETF Depository Receipts on the Thailand Stock Exchange marks a significant milestone in the internationalization of China's capital markets, providing Thai investors with direct access to China's core technology assets [2][3]. Group 1: Internationalization of ChiNext 50 ETF - The ChiNext 50 ETF Depository Receipts were listed on November 25, providing Thai investors with a new investment product focused on the ChiNext 50 Index [2][3]. - This is the first time a Chinese A-share listed ETF has been issued in Thailand in the form of Depository Receipts, indicating a growing interest in Chinese technology assets in Southeast Asia [2][3]. - The Shenzhen Stock Exchange aims to enhance the internationalization of the ChiNext market and facilitate global investors in sharing the benefits of China's technological innovation [2][3]. Group 2: Market Demand and Product Details - The demand for investment in Chinese core assets among Thai investors has surged, driven by China's high-quality economic development and capital market reforms [3]. - The Invesco China ChiNext 50 ETF, established in December 2022, has surpassed 50 billion in total assets and maintains a low fee structure of 0.2% [3][4]. - InnovestX, a leading Thai brokerage, partnered with Invesco to issue the Depository Receipts, enhancing the accessibility of the ChiNext 50 Index for local investors [3][4]. Group 3: Performance of ChiNext 50 Index - As of November 18, the ChiNext 50 Index has shown a cumulative increase of 56.49% this year, outperforming other broad-based indices [5]. - The average revenue growth rate for the ChiNext 50 constituent stocks was 21.07% year-on-year for the mid-year report, with net profit growth at 16.63% [5]. - In the third quarter, the revenue growth rate remained strong at 15.75%, while net profit growth increased to 22.58% [5]. Group 4: Sector Focus and Composition - The ChiNext 50 Index focuses on high-tech sectors such as new energy, advanced manufacturing, and biomedicine, making it an attractive investment for capturing China's technological development [4][6]. - The index excludes traditional cyclical industries, emphasizing a higher concentration of technology stocks, with significant weights in battery, communication equipment, and photovoltaic sectors [6]. - The top three sectors by weight in the ChiNext 50 Index are batteries (29.76%), communication equipment (18.62%), and photovoltaic equipment (8.22%) [6]. Group 5: Global Integration and Revenue - The leading companies in the ChiNext are deeply integrated into the global value chain, with 35.17% of their revenue coming from overseas markets in 2024, which is higher than many major broad-based indices [7]. - The average overseas revenue proportion for the top ten weighted stocks in the ChiNext 50 Index is 47.96%, indicating strong international market engagement [7].

Core Viewpoint - The listing of the Invesco Great Wall ChiNext 50 ETF Depository Receipts on the Thailand Stock Exchange marks a significant milestone in the internationalization of China's ChiNext index, providing Thai investors with direct access to China's core technology assets [3][4]. Group 1: Internationalization of ChiNext Index - The ChiNext 50 ETF Depository Receipts are the first of their kind from China's A-share market to be listed in Thailand, enhancing the international presence of the ChiNext index [3][4]. - The Shenzhen Stock Exchange aims to leverage this listing to further internationalize the ChiNext investment platform and facilitate global investors' access to China's technological innovations [3][4]. Group 2: Market Demand and Product Details - There is a growing demand among Thai investors for investment products related to China's core assets, driven by China's high-quality economic development and capital market reforms [4]. - The Invesco Great Wall ChiNext 50 ETF was established in December 2022 and currently has a total scale exceeding 50 billion, with a low fee structure of 0.2% [4][5]. Group 3: Performance of ChiNext 50 Index - As of November 18, 2025, the ChiNext 50 Index has shown a cumulative increase of 56.49%, outperforming other broad-based indices [6]. - The index's constituent stocks reported an average revenue growth of 21.07% and a net profit growth of 16.63% in the first half of 2025, with continued strong performance in the third quarter [6][7]. Group 4: Sector Focus and Composition - The ChiNext 50 Index focuses on high-tech sectors such as new energy, advanced manufacturing, and biomedicine, capturing the benefits of China's technological advancements [5][8]. - The top three sectors by weight in the ChiNext 50 Index are batteries (29.76%), communication equipment (18.62%), and photovoltaic equipment (8.22%) [8]. Group 5: Global Integration and Revenue - The leading companies in the ChiNext 50 Index are deeply integrated into the global value chain, with 35.17% of their revenue coming from overseas markets in 2024, which is higher than many broad-based indices [8]. - The average overseas revenue proportion for the top ten weighted stocks in the index is 47.96%, indicating a strong international market presence [8].

Core Points - The three major indices opened higher, with the Shenzhen Component Index and the ChiNext Index both rising over 2%, while the Shanghai Composite Index increased by over 1% [1] - The ChiNext 50 ETF (159949) rose by 2.60% to 1.420 CNY, with a turnover rate of 5.52% and a trading volume of 1.399 billion CNY [1][2] - The ETF has seen a net inflow of funds for seven consecutive trading days, with a net inflow of 915 million CNY over the past five trading days [2][4] - As of November 24, 2025, the latest circulating scale of the ETF is 24.741 billion CNY, ranking first among similar ETFs [2][4] - The top ten holdings of the ChiNext 50 ETF include leading companies such as CATL, Zhongji Xuchuang, Dongfang Wealth, and others [3][4] Industry Insights - The PCB sector is experiencing a rebound, with Shenghong Technology rising over 6% amid news that Meta Platforms is considering a multi-billion dollar purchase of Google's TPU for data center construction [4] - Recent reports indicate that NVIDIA's FY26Q3 performance and FY26Q4 guidance exceeded expectations, while Google's Gemini 3 model has significantly improved performance, suggesting that the AI industry is still in an upward phase [5] - The PCB sector is viewed as a key opportunity for investment, particularly in relation to AI chip upgrades, with continuous recommendations for major manufacturers in the AI PCB sector [5]

Core Viewpoint - The launch of the ChiNext 50 Index Depository Receipts (DRs) on the Thailand Stock Exchange marks a significant milestone in the internationalization of the ChiNext 50 Index, providing Thai investors with direct access to China's core technology assets [1][2]. Group 1: Internationalization of ChiNext 50 Index - The ChiNext 50 Index has successfully expanded internationally, having previously listed on major European exchanges and now entering the Thai market [1]. - The listing of the ChiNext 50 ETF DRs is the first of its kind for A-share ETFs in Thailand, symbolizing the entry of Chinese core technology assets into the Southeast Asian market [1][2]. - The Shenzhen Stock Exchange aims to enhance the internationalization of the ChiNext market and facilitate global investors' access to China's technological innovations [1]. Group 2: Market Demand and Product Details - There is a growing demand among Thai investors for investment products related to Chinese core assets, driven by China's high-quality economic development and capital market reforms [2]. - The ChiNext 50 ETF, established in December 2022, has an overall scale exceeding 50 billion, with a low fee structure of 0.2% [2]. - InnovestX, a leading Thai brokerage, collaborates with Invesco to issue the DRs, which can be traded like stocks on the exchange [2]. Group 3: Performance of ChiNext 50 Index - As of November 18, the ChiNext 50 Index has shown a cumulative increase of 56.49%, outperforming other broad-based indices [4]. - The index's constituent stocks reported an average revenue growth of 21.07% and a net profit growth of 16.63% in the mid-year report for 2025 [4]. - In the third quarter, the revenue growth for the constituent stocks remained strong at 15.75%, with net profit growth rising to 22.58% [4]. Group 4: Key Constituents and Sector Focus - The top ten weighted stocks in the ChiNext 50 Index include leading companies such as CATL and Mindray, with an average revenue growth of 48.93% and net profit growth of 82.03% [5]. - The index focuses on high-tech sectors such as new energy, high-end manufacturing, and biomedicine, reflecting a higher concentration of technology compared to traditional industries [5][6]. - The three largest weighted sectors in the ChiNext 50 Index are batteries (29.76%), communication equipment (18.62%), and photovoltaic equipment (8.22%) [6].

Core Viewpoint - The article reports on the performance of the Chuangye 50 ETF (159682), highlighting its increase of 2.76% as of the midday close on November 25, with a trading volume of 279 million yuan [1] Group 1: ETF Performance - Chuangye 50 ETF (159682) closed at 1.379 yuan, with a trading volume of 2.79 billion yuan [1] - The ETF's performance benchmark is the return rate of the ChiNext 50 Index [1] - Since its establishment on December 23, 2022, the fund has achieved a return of 34.32%, while its return over the past month has been -8.44% [1] Group 2: Top Holdings - Key stocks in the Chuangye 50 ETF include: - Ningde Times, up 1.35% - Zhongji Xuchuang, up 6.06% - Dongfang Wealth, up 0.51% - Xinyi Sheng, up 6.03% - Sunshine Power, up 5.87% - Shenghong Technology, up 6.15% - Huichuan Technology, up 1.35% - Mindray Medical, up 0.73% - Yiwei Lithium Energy, up 1.82% - Tonghuashun, up 0.73% [1]

Group 1 - The ChiNext 50 Index (399673) has shown strong growth, with notable increases in constituent stocks such as Shenghong Technology (300476) up by 7.40%, and Xinyi Sheng (300502) up by 5.97% [1] - The AI sector is experiencing a boost, driven by Google's announcement of a plan to increase computing power by 1000 times over the next 4-5 years, doubling every six months to support AI infrastructure competition [1] - HSBC's latest report indicates that the acceleration of AI server iterations is driving a dual cycle of technological and price increases for core components like printed circuit boards (PCBs) and copper-clad laminates (CCLs) [1] Group 2 - The demand for domestic AI chip production is increasing due to foreign restrictions on China's AI sector, leading to a significant push for domestic alternatives [2] - The rapid growth in the usage of large AI models is driving an increase in upstream computing power demand, with North America's major cloud providers increasing capital expenditures year-on-year [2] - The ChiNext 50 Index reflects the performance of the top 50 stocks in the ChiNext market based on average daily trading volume, representing well-known, large-cap, and liquid companies [2][3] Group 3 - As of October 31, 2025, the top ten weighted stocks in the ChiNext 50 Index account for 70.15% of the index, including companies like CATL (300750) and Mindray (300760) [3]

Core Insights - A total of 1,118 stocks in the Shanghai and Shenzhen markets have experienced net outflows of main funds for five consecutive days or more as of November 24 [1] - The stock with the longest continuous net outflow is Daye Intelligent, with 25 days of outflows, followed by Jindun Co., which has seen 24 days of outflows [1] - The largest total net outflow amount is from Shannon Chip, with a cumulative outflow of 5.811 billion yuan over eight days [1] Summary by Category Main Fund Outflow Duration - Daye Intelligent: 25 days of net outflow [1] - Jindun Co.: 24 days of net outflow [1] - Other notable stocks include Zhongke Shuguang (12 days) and SMIC (7 days) [1] Total Net Outflow Amount - Shannon Chip: 5.811 billion yuan over 8 days [1] - Zhaoyi Innovation: 5.267 billion yuan over 7 days [1] - Zhongke Shuguang: 4.322 billion yuan over 12 days [1] - SMIC: 3.861 billion yuan over 7 days [1] Proportion of Net Outflow to Trading Volume - Tiantan Biological: 8.97% of trading volume with a 5% decline over 6 days [1] - Zhaoyi Innovation: 11.21% of trading volume with a 21.24% decline over 7 days [1] - Other stocks with significant outflow proportions include Dongfang Wealth (10.61%) and Jiangbolong (9.70%) [1]

Investment Rating - The report maintains a "Buy" rating for several companies including Tian Shi Li, Xin Da Biology, and WuXi AppTec, with a focus on the innovative drug industry and high-end medical devices [3][25]. Core Insights - The small nucleic acid drug sector is experiencing significant advancements, marking the dawn of a new wave of innovative drugs. The industry is entering a golden development period driven by technological breakthroughs and commercial validation, with a recommendation to focus on leading innovative drug companies and those benefiting from the overall industry upturn [1][20][24]. Summary by Sections Market Review - The A-share pharmaceutical and biotechnology index fell by 4.32%, underperforming the CSI 300 index by 0.54 percentage points, while outperforming the ChiNext index by 1.92 percentage points, ranking 30th among 31 sub-industries. The H-share Hang Seng Healthcare Index dropped by 7.5%, underperforming the Hang Seng Index by 2.41 percentage points [1][15][9]. R&D Progress - Recent IND applications have been initiated for Heng Rui Medicine's HRS-1358 and HRS-3738, and clinical applications for SHR-9539 and JS207 have also been newly undertaken. Additionally, Zheng Da Tian Qing's TQB2934 is in Phase I clinical trials, while Gan Li Pharmaceutical's Bo Fan Gu Lu Tai is in Phase III [1][28]. Key Company Recommendations - The report highlights key companies to watch, including Heng Rui Medicine (A+H), Xin Da Biology (H), WuXi AppTec (A+H), Qian Yan Biology, Chengdu Xian Dao, and Jian Kai Technology, focusing on those with leading technology platforms and differentiated pipelines [1][25][24]. Investment Strategy - The report emphasizes the importance of clinical value in the pharmaceutical sector, suggesting that investments should focus on innovative drug chains and medical devices that meet clinical needs. The strategy is based on a three-stage clinical value framework [2][24]. Financial Forecasts - The report provides earnings per share (EPS) forecasts for key companies, with Tian Shi Li projected at 0.64 CNY for 2024, Xin Da Biology at -0.06 CNY, and WuXi AppTec at 3.27 CNY for 2024, indicating a positive outlook for several firms [3].

11 月 21 日，以 " 智领健康未来 " 为主题的 2025 华夏大健康产业发展暨康复服务大会在北京召开。作为连续四届引领行业风向的标杆盛会，科技与创新 始终是贯穿全程的灵魂主线，而医疗健康企业在环境、社会及治理方面的表现同样被社会各界关注。 万得 ESG高级分析师 受邀发表了主题演讲，详细介绍了蒲公英指数的构建背景、评估体系及市场表现，强调该指数为医疗健康行业可持续发展提供了重 要参考。 万得首先介绍了 Wind 万得的业务背景： "Wind 是一家专业化的信息服务机构，为金融领域开发了信息检索、数据提取及组合管理等专业工具，是国内外 机构投资者的重要合作伙伴。 " 她特别指出， Wind 构建的独立 ESG 评级体系已广泛应用于政策研究、金融决策和企业实践当中，例如国务院发展研究 中心发布的报告及可持续挂钩债券发行实践。 蒲公英指数亦是 Wind ESG 评级体系的一次创新性应用。该指数由华夏时报大健康研究院与万得联合研发，从医疗健康领域 A 股 495 家公司中精选前 50 家组成 " 蒲公英 50 指数 " ，港股 262 家公司中精选 30 家组成 " 蒲公英 30 指数 " ，每月根据 ESG ...